Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becatecarin in Pediatric Relapsed/Refractory Neuroblastoma
NCT00003737Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 1999
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of becatecarin in neuroblastoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 1999; status: completed.
02
Drugs
becatecarin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00003737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003737.